BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

971 related articles for article (PubMed ID: 29860944)

  • 1. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
    Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease.
    Thal DR; Papassotiropoulos A; Saido TC; Griffin WS; Mrak RE; Kölsch H; Del Tredici K; Attems J; Ghebremedhin E
    Acta Neuropathol; 2010 Aug; 120(2):169-83. PubMed ID: 20535486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
    Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
    Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
    Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
    Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic profiling in cerebral amyloid angiopathy reveals an overlap with CADASIL highlighting accumulation of HTRA1 and its substrates.
    Zellner A; Müller SA; Lindner B; Beaufort N; Rozemuller AJM; Arzberger T; Gassen NC; Lichtenthaler SF; Kuster B; Haffner C; Dichgans M
    Acta Neuropathol Commun; 2022 Jan; 10(1):6. PubMed ID: 35074002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy.
    Endo Y; Hasegawa K; Nomura R; Arishima H; Kikuta KI; Yamashita T; Inoue Y; Ueda M; Ando Y; Wilson MR; Hamano T; Nakamoto Y; Naiki H
    Acta Neuropathol Commun; 2019 Jan; 7(1):12. PubMed ID: 30691533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
    Attems J; Lintner F; Jellinger KA
    Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics-based investigation of cerebrovascular molecular mechanisms in cerebral amyloid angiopathy by the FFPE-LMD-PCT-SWATH method.
    Handa T; Sasaki H; Takao M; Tano M; Uchida Y
    Fluids Barriers CNS; 2022 Jul; 19(1):56. PubMed ID: 35778717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy.
    Manousopoulou A; Gatherer M; Smith C; Nicoll JAR; Woelk CH; Johnson M; Kalaria R; Attems J; Garbis SD; Carare RO
    Neuropathol Appl Neurobiol; 2017 Oct; 43(6):492-504. PubMed ID: 27543695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy.
    Inoue Y; Ueda M; Tasaki M; Takeshima A; Nagatoshi A; Masuda T; Misumi Y; Kosaka T; Nomura T; Mizukami M; Matsumoto S; Yamashita T; Takahashi H; Kakita A; Ando Y
    Acta Neuropathol; 2017 Oct; 134(4):605-617. PubMed ID: 28478503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy.
    de Jager M; Boot MV; Bol JG; Brevé JJ; Jongenelen CA; Drukarch B; Wilhelmus MM
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):255-72. PubMed ID: 25871449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.
    Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease.
    Thal DR; Griffin WS; de Vos RA; Ghebremedhin E
    Acta Neuropathol; 2008 Jun; 115(6):599-609. PubMed ID: 18369648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
    van Helmond ZK; Miners JS; Bednall E; Chalmers KA; Zhang Y; Wilcock GK; Love S; Kehoe PG
    Neuropathol Appl Neurobiol; 2007 Jun; 33(3):317-27. PubMed ID: 17493012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
    Cho HS; Hyman BT; Greenberg SM; Rebeck GW
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral amyloid angiopathy and dementia.
    Tian J; Shi J; Mann DM
    Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.